 |
인쇄하기
취소
|
Phase II study for Zydena successfully completed in U. S.
The phase II clinical study of Zydena in the United States was successfully completed and may give a good chance for its FDA approval in due course.
Dong-A PharmTec, a subsidiary of Dong-A playing a major role for the overseas clinical studies, said recently that the company conducted the phase II clinical study for Zydena against total 340 patients treated for 12 weeks and the results came ...
Dong-A PharmTec, a subsidiary of Dong-A playing a major role for the overseas clinical studies, said recently that the company conducted the phase II clinical study for Zydena against total 340 patients treated for 12 weeks and the results came ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.